What Is Kisspeptin? Definition and What Research Reports
Kisspeptin is a family of peptides produced from the KISS1 gene that act on the receptor GPR54 (KISS1R), mostly in the brain. In published research it is described as an upstream trigger for gonadotropin-releasing hormone neurons and therefore for the reproductive hormone axis. Studies have also examined links to energy balance, glucose handling, prolactin, bone cells and the blood–brain barrier. This glossary entry defines the term, separates it from common misuse, and summarises what the cited literature reported.
Plain definition
Kisspeptin is the name given to a small family of signalling peptides made in the body from a gene called KISS1. They are produced mainly by clusters of nerve cells in the hypothalamus — the part of the brain that coordinates hormones — and they attach to a receptor called GPR54 (also written KISS1R). In the published literature, kisspeptin is most often described as the switch that sits upstream of the reproductive hormone cascade: kisspeptin neurons stimulate gonadotropin-releasing hormone (GnRH) neurons, which in turn drive the pituitary and the gonads. A 2022 review in Frontiers in Endocrinology described kisspeptin signalling as a central regulator of the hypothalamic–pituitary–gonadal (HPG) axis and of reproduction (PMID 35837314). In short: kisspeptin is a naturally occurring brain peptide that research links to the control of reproductive hormones, and which has also been studied in metabolic and non-reproductive contexts.
The term in biochemical and regulatory terms
The KISS1 gene encodes a precursor protein that is cleaved into peptides of different lengths. The longest commonly described form contains 54 amino acids and is often written kisspeptin-54; shorter fragments share the same C-terminal end and include kisspeptin-10, the decapeptide most frequently used in laboratory work. All of these forms are described as ligands for the G protein-coupled receptor GPR54/KISS1R, which is why the receptor name appears alongside the peptide name in most papers. A 2024 study in Nature Communications, for example, framed its work explicitly as kisspeptin-10 binding to Gpr54 (PMID 38346942).
Terminology has shifted over time, which is a frequent source of confusion. The receptor was originally catalogued as an orphan receptor (GPR54) before its ligand was identified; "metastin" appears in older cancer-biology literature for the same peptide family. Modern papers generally use kisspeptin for the peptide and KISS1R or GPR54 for the receptor, with the numeral suffix indicating peptide length.
Quick reference
| Item | What the literature uses it to mean |
|---|---|
| Kisspeptin | Peptide family encoded by KISS1, acting at GPR54/KISS1R |
| Kisspeptin-54 | The longer cleavage product of the precursor protein |
| Kisspeptin-10 (KP-10) | The 10-amino-acid C-terminal fragment used widely in experiments (PMID 38978171) |
| GPR54 / KISS1R | The receptor kisspeptins bind |
| HPG axis | Hypothalamus → pituitary → gonads hormone pathway (PMID 35837314) |
| Metastin | Older synonym from cancer-biology literature |
What the published literature reports
Reproductive axis
The dominant theme across reviews is regulation of reproduction. Researchers describing the HPG axis in a 2022 Frontiers in Endocrinology review placed kisspeptin neurons upstream of GnRH release and treated kisspeptin signalling as essential to normal reproductive control (PMID 35837314). Kisspeptin expression is not confined to the brain: a 2022 report in Development & Reproduction examined kisspeptin expression in the adult hamster testis, indicating that the peptide is also present in gonadal tissue (PMID 36285151).
Not every anatomical connection has turned out to be functionally required. A 2023 mouse study in Brain Structure & Function examined kisspeptin neuron projections to oxytocin neurons and reported that these projections were not necessary for parturition in the mouse (PMID 37389617). The study is a useful reminder that the presence of a neural pathway does not establish that it is indispensable.
Energy balance, metabolism and glucose
A second research strand connects kisspeptin to nutritional state. A 2020 review in Nature Reviews Endocrinology framed kisspeptin as a link between energy balance and reproduction, describing how metabolic signals converge on kisspeptin neurons (PMID 32427949). A 2022 review in The Journal of Physiology covered emerging roles for kisspeptin in metabolism more broadly (PMID 33977536). A separate 2019 review in Seminars in Reproductive Medicine addressed kisspeptin and glucose homeostasis specifically, indicating that the peptide has been studied beyond the reproductive system (PMID 31869842).
Prolactin and other pituitary hormones
Kisspeptin has also been examined in relation to prolactin, the subject of a dedicated 2019 review in Seminars in Reproductive Medicine (PMID 31847029). In a different direction, a 2018 study in The Journal of Endocrinology reported that kisspeptin antagonists stimulated growth hormone in ewes — an effect produced by blocking, not activating, kisspeptin signalling (PMID 29549187). Findings of that kind are routinely misquoted in secondary sources as though the peptide itself raised growth hormone.
Non-reproductive and preclinical directions
Two recent preclinical papers illustrate how far the research field has spread. A 2024 Nature Communications study reported that kisspeptin-10 binding to Gpr54 in osteoclasts prevented bone loss by activating Dusp18-mediated dephosphorylation of Src (PMID 38346942). A 2025 study in Neurotoxicology reported that kisspeptin-10 protected against HIV-1 Tat-induced blood–brain barrier dysfunction and neuroinflammation via the RhoA/ROCK pathway in a model system (PMID 40712838). A 2022 review in Current Opinion in Pharmacology surveyed novel therapeutic avenues for kisspeptin, reflecting continuing interest in translation (PMID 36413854). None of these reports establishes an approved human therapy.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeHow the term is used — and where it is misused
In academic writing, "kisspeptin" usually refers to the endogenous peptide family or to a defined synthetic fragment used as a research tool, with the receptor and species stated. In informal peptide discussion the term is often flattened in ways the literature does not support:
- Treating "kisspeptin" and "kisspeptin-10" as interchangeable. Papers specify the fragment; a urine-detection method paper described kisspeptin-10 by name as a distinct, doping-relevant peptide (PMID 38978171).
- Presenting animal or cell findings as human outcomes. The osteoclast and blood–brain barrier reports cited above were preclinical (PMID 38346942, PMID 40712838).
- Confusing agonist and antagonist results, as with the ewe growth hormone study, where antagonists produced the reported stimulation (PMID 29549187).
- Calling it a "libido peptide." The reviewed literature frames kisspeptin as a regulator of the HPG axis and of metabolic–reproductive integration, not as a single-purpose compound (PMID 35837314, PMID 32427949).
Related terms
- GnRH (gonadotropin-releasing hormone) — the hypothalamic hormone downstream of kisspeptin in HPG-axis descriptions (PMID 35837314).
- KISS1R / GPR54 — the receptor target named in mechanistic studies (PMID 38346942).
- Kisspeptin antagonist — a compound that blocks the receptor rather than activating it (PMID 29549187).
- Energy balance — the metabolic context in which kisspeptin neurons are frequently discussed (PMID 32427949).
Tracking research? Log entries with dates, lots and notes — records, never plans.
Get the appKisspeptin Safety and Adverse Events: What Studies Report
The verified literature summarised on this page is largely mechanistic, review-based or preclinical, and it does not provide a characterised human adverse-event profile for kisspeptin or its fragments. Reviews of therapeutic avenues discussed potential applications rather than establishing safety conclusions (PMID 36413854), and the bone and blood–brain barrier findings were reported in laboratory models (PMID 38346942, PMID 40712838). Readers should treat any confident safety claim about this peptide as going beyond what the cited papers support.
Status notes
Kisspeptin-10 was described in a 2024 analytical chemistry paper as a novel doping-relevant peptide, and researchers there developed a liquid chromatography high-resolution mass spectrometry method for detecting it in urine (PMID 38978171). That context matters for anyone reading about the peptide in a sport setting, because detection methods exist. Materials labelled "research use only" are not approved medicines.
This page is for educational purposes only and is not medical advice; consult a licensed physician about any health question or before making decisions related to any substance discussed here.
Want the full course? Every compound, evidence-graded and cited, inside PeptideU.
Start learning freeReferences
- The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction (Frontiers in Endocrinology, 2022)
- Metabolic regulation of kisspeptin - the link between energy balance and reproduction (Nature Reviews Endocrinology, 2020)
- Emerging roles for kisspeptin in metabolism (The Journal of Physiology, 2022)
- Kisspeptin and Glucose Homeostasis (Seminars in Reproductive Medicine, 2019)
- Kisspeptin and Prolactin (Seminars in Reproductive Medicine, 2019)
- Stimulation of growth hormone by kisspeptin antagonists in ewes (The Journal of Endocrinology, 2018)
- Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src (Nature Communications, 2024)
- Kisspeptin-10 protects against HIV-1 Tat-induced blood-brain barrier dysfunction and neuroinflammation via RhoA/ROCK pathway (Neurotoxicology, 2025)
- Kisspeptin neuron projections to oxytocin neurons are not necessary for parturition in the mouse (Brain Structure & Function, 2023)
- Expression of Kisspeptin in the Adult Hamster Testis (Development & Reproduction, 2022)
- Novel therapeutic avenues for kisspeptin (Current Opinion in Pharmacology, 2022)
- Investigating the detection of the novel doping-relevant peptide kisspeptin-10 in urine using liquid chromatography high-resolution mass spectrometry (Biomedical Chromatography, 2024)
Frequently asked questions
What does kisspeptin do in the body, according to research?▾
Published reviews describe kisspeptin as a hypothalamic peptide that acts on the GPR54/KISS1R receptor and sits upstream of gonadotropin-releasing hormone neurons, making it central to control of the hypothalamic-pituitary-gonadal axis and reproduction (PMID 35837314). Reviews have also reported links between kisspeptin neurons and metabolic signals related to energy balance (PMID 32427949).
What is the difference between kisspeptin-10 and kisspeptin-54?▾
Both come from the same KISS1-derived precursor and share the C-terminal region that binds GPR54; the numeral indicates peptide length. Kisspeptin-10 is the ten-amino-acid fragment most often named in experimental work, including a 2024 mechanistic study in osteoclasts (PMID 38346942) and a 2024 analytical paper on detecting it in urine (PMID 38978171).
Is kisspeptin only involved in reproduction?▾
No. Alongside its reproductive role (PMID 35837314), reviews have examined kisspeptin in glucose homeostasis (PMID 31869842) and in metabolism more broadly (PMID 33977536), and a separate review addressed kisspeptin and prolactin (PMID 31847029). Preclinical work has also reported effects in bone cells (PMID 38346942), so the research field extends well beyond reproduction.
Does kisspeptin increase growth hormone?▾
That claim usually misreads one study. Researchers reported in 2018 that kisspeptin antagonists — compounds that block the receptor — stimulated growth hormone in ewes (PMID 29549187). The reported effect came from blocking kisspeptin signalling in a sheep model, not from administering the peptide, and the finding has not been shown to translate to humans in the papers cited here.
Is kisspeptin an approved medicine?▾
The cited literature does not describe an approved kisspeptin product. A 2022 review discussed novel therapeutic avenues for kisspeptin, indicating the field remains exploratory (PMID 36413854). A 2024 paper described kisspeptin-10 as a novel doping-relevant peptide and developed a urine detection method for it (PMID 38978171). This information is educational only and is not medical advice.
What do studies report about kisspeptin safety?▾
The verified papers summarised here are mainly reviews and preclinical studies and do not establish a human adverse-event profile. Bone and blood-brain barrier findings were reported in laboratory models (PMID 38346942, PMID 40712838), and therapeutic reviews discussed possibilities rather than safety conclusions (PMID 36413854). Questions about risk belong with a licensed physician.
Where are kisspeptin and its receptor found?▾
Reviews place kisspeptin neurons in the hypothalamus, where they regulate the reproductive axis through GPR54/KISS1R signalling (PMID 35837314). Expression is not restricted to the brain: a 2022 study reported kisspeptin expression in the adult hamster testis (PMID 36285151), and a 2024 report identified Gpr54 on osteoclasts, a bone cell type (PMID 38346942).
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.